Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Eisai’s anti-cancer agent LENVIMA receives orphan drug designation

pharmaceutical-technologyMarch 16, 2021

Tag: Eisai , Lenvima , uterine body cancer

PharmaSources Customer Service